• Ibrutinib-Induced AF Linked to Off-Target CSK Inhibition: Me

  2026-05-13

  This study identifies C-terminal Src kinase (CSK) inhibition as the mechanistic cause of atrial fibrillation (AF) in ibrutinib-treated mice, separating this effect from Bruton tyrosine kinase (BTK) targeting. The findings clarify safety concerns for kinase inhibitor development and highlight the importance of selectivity in drug design and experimental research.

• Solving Adipocyte Gene Delivery Challenges with ATS-9R (C872

  2026-05-13

  This article addresses common laboratory obstacles in targeted gene delivery to adipocytes and demonstrates how ATS-9R (Adipocyte-targeting sequence-9-arginine, SKU C8721) offers reproducible, data-backed solutions. By emphasizing protocol optimization, assay compatibility, and vendor selection, it empowers researchers to enhance workflow reliability and experimental outcomes using this non-viral gene delivery fusion oligopeptide.

• Procainamide Hydrochloride Reduces Cisplatin Liver Toxicity

  2026-05-12

  This study demonstrates that procainamide hydrochloride, beyond its established use as a cardiac sodium channel blocker, significantly reduces cisplatin-induced hepatotoxicity in rats. The chemoprotection appears linked to altered platinum complex formation and subcellular distribution, offering new mechanistic insight for cross-domain research in drug toxicity mitigation.

• Lamotrigine for Sodium Channel Modulation: Advanced Research

  2026-05-12

  Lamotrigine (6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine) is a gold-standard tool for dissecting sodium channel and serotonin pathways in both epilepsy and cardiac arrhythmia studies. High-purity supply from APExBIO and robust protocol recommendations enable precise, reproducible results across diverse translational neuroscience and cardiology research contexts.

• Ceftazidime: Third-Generation Cephalosporin for Infection Re

  2026-05-11

  Harness the power of Ceftazidime, a third-generation cephalosporin, for reproducible Gram-negative infection models and multidrug resistance surveillance. This guide translates recent resistance dynamics and experimental insights into actionable lab protocols, helping researchers optimize outcomes in studies of Pseudomonas and Enterobacteriaceae.

• Tin Mesoporphyrin IX (chloride): Expanding Horizons in Heme

  2026-05-11

  Explore how Tin Mesoporphyrin IX (chloride) empowers next-generation research into heme oxygenase inhibition. This in-depth article details its unique mechanism, protocol precision, and advanced applications beyond current literature.

• DDX23-Caspase Axis in SVA Infection: Mechanistic Insights an

  2026-05-10

  Li et al. reveal a dual mechanism by which the host RNA helicase DDX23 restricts Senecavirus A (SVA) replication and how viral proteins 3A and 2B counteract this restriction via caspase-mediated degradation. These findings clarify host-pathogen interactions in porcine antiviral defense and highlight new targets for antiviral strategy development.

• EZ Cap EGFP mRNA 5-moUTP: Optimized Workflows for High-Fidel

  2026-05-09

  EZ Cap™ EGFP mRNA (5-moUTP) enables robust, immune-evasive fluorescent reporting, outperforming traditional mRNA reagents in both stability and translational yield. This guide details advanced workflows and troubleshooting for maximizing reliability in gene expression studies, leveraging state-of-the-art insights on mRNA delivery and formulation.

• Anti-Fibrotic Actions of 1-Phenyl-2-Pentanol in Hepatic Stel

  2026-05-08

  This study identifies 1-phenyl-2-pentanol from Moringa oleifera as a novel inhibitor of hepatic stellate cell activation, acting through TGF-β1 and Wnt/β-catenin pathway modulation. The findings provide mechanistic insight for developing anti-fibrotic therapies and refining in vitro models of liver fibrosis.

• Bestatin Hydrochloride: Applied Angiogenesis & Tumor Inhibit

  2026-05-08

  Bestatin hydrochloride (Ubenimex) is redefining experimental precision in angiogenesis and tumor invasion research through robust inhibition of aminopeptidase N and B. This guide translates pivotal findings and troubleshooting strategies into actionable workflows for cancer and neuroscience labs.

• Patient-Derived Gastric Cancer Assembloids Advance Drug Rese

  2026-05-07

  This study introduces a patient-derived gastric cancer assembloid model that integrates tumor organoids with matched stromal cell subpopulations, offering a more physiologically relevant platform for preclinical research. The model reveals how stromal components influence drug response and resistance, supporting the optimization of targeted therapies and advancing personalized medicine approaches.

• Laminin (925-933): Technical Guide for Cell Adhesion Assays

  2026-05-07

  Laminin (925-933) is a defined, synthetic peptide for modulating cell attachment and chemotaxis in in vitro assays, especially where precise extracellular matrix cues are required. It is best used for receptor-specific cell adhesion and migration workflows, but is not intended for diagnostic or in vivo applications.

• Applied Workflows with Losartan: Angiotensin II Antagonist i

  2026-05-06

  Leverage Losartan’s precision as a selective angiotensin II receptor antagonist to design rigorous hypertension and tumor microenvironment assays. This guide translates new mechanistic insights and troubleshooting strategies into actionable protocols for cardiovascular and oncology research.

• Canagliflozin Hemihydrate: Precision SGLT2 Inhibition in Met

  2026-05-06

  Canagliflozin hemihydrate from APExBIO offers researchers a pathway-specific, high-purity SGLT2 inhibitor for advanced glucose metabolism and diabetes studies. Its robust selectivity ensures experimental clarity, helping to delineate renal glucose reabsorption mechanisms without confounding mTOR pathway interference.

• SGI-1027: A Precision DNA Methyltransferase Inhibitor for Ca

  2026-05-05

  SGI-1027 is a potent, quinoline-based DNA methyltransferase inhibitor uniquely suited for targeted gene reactivation and overcoming drug resistance in cancer research. By integrating data-backed workflows and troubleshooting strategies, this guide empowers epigenetics labs to harness SGI-1027’s dual mechanism for maximal experimental clarity.

16409 records 1/1094 page Next 12345 下5页 Last page